Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01524913 · ClinicalTrials.gov registry record · Phase 4
A Double Blind Study Comparing Hyaluronic Acid, Corticosteroid and Placebo During Arthrocentesis for Temporomandibular Joint (TMJ) Dysfunction
A Phase 4 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 102
- Enrollment target
NCT01524913 is a Phase 4 study that has completed, run by Emory University. The registered enrollment target is 102 participants.
The verdict
NCT01524913, a Phase 4 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 102 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the administration of hyaluronic acid or corticosteroid during arthrocentesis of the temporomandibular joint provides additional pain relief and improved function. The overall hypothesis for the study is that hyalgan will result in a 30% reduction in the mean visual analogue scale (VAS) at one month when compared to celestone and placebo.
Interventions
- DRUG Corticosteroid
- DRUG Lactated Ringers
- DRUG Hyaluronic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2012-01 |
| Est. Completion | 2016-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01524913
The ClinicalTrials.gov registry entry for NCT01524913 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Corticosteroid is the first listed.
NCT01524913 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01524913 about?
NCT01524913 is a clinical study titled "A Double Blind Study Comparing Hyaluronic Acid, Corticosteroid and Placebo During Arthrocentesis for Temporomandibular Joint (TMJ) Dysfunction". The purpose of this study is to determine whether the administration of hyaluronic acid or corticosteroid during arthrocentesis of the temporomandibular joint provides additional pain relief and improved function. The overall hypothesis for the study is that hyalgan will result in a 30% reduction i...
What is the current status of trial NCT01524913?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 102 participants. The study started on 2012-01. Estimated completion is 2016-04.
What interventions are being tested in trial NCT01524913?
The interventions under investigation include: Corticosteroid (DRUG), Lactated Ringers (DRUG), Hyaluronic acid (DRUG).
Who is sponsoring clinical trial NCT01524913?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.